Market Share of MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Industry
The SGLT 2 inhibitors market is highly consolidated, with a few significant manufacturers having a Middle East and Africa market presence. The joint ventures between players in the recent past have helped the companies strengthen their market presence. For example, Eli Lilly and Boehringer Ingelheim manufacture Jardiance, a popular SGLT 2 class drug.
MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market Leaders
Astrazeneca
Bristol-Myers Squibb
Eli Lilly
Janssen
Astellas
*Disclaimer: Major Players sorted in no particular order